CTNM: Proposed sale of 2,500 shares via option exercise

CTNM: Proposed sale of 2,500 common shares by exercise of stock options for cash.

Rhea-AI Filing Summary

CTNM: Proposed sale of 2,500 common shares by exercise of stock options for cash. The filing shows 2,500 Common shares to be sold on 07/08/2026 via an Exercise of Stock Options with cash indicated. The notice also records prior 10b5-1 sales by Carmine Stengone of 10,000 shares on 06/30/2026 for $160,080.

Insights

Insider Transactions Analyst

Routine disclosure of a proposed exercised‑option sale and a recent 10b5‑1 sale.

The notice lists 2,500 shares proposed for sale via exercise of options on 07/08/2026, and prior automated 10b5-1 sales of 10,000 shares on 06/30/2026 for $160,080. These entries are typical broker‑filed resale notices.

Cash treatment is stated for the exercise. Subsequent filings will show whether the proposed sale was completed.

Corporate Governance Specialist

Disclosure signals standard insider liquidity under a trading plan and option exercise.

The record cites an Exercise of Stock Options as the mechanism for the 2,500 share sale and separately notes 10b5‑1 sales earlier in the quarter. The form lists the broker and transaction dates but does not state proceeds recipient beyond "Cash."

Monitor subsequent SEC notices for confirmation of settlement and any additional insider filings.

Key Figures

Proposed shares to sell: 2,500 shares Prior 10b5-1 shares sold: 10,000 shares Proceeds from prior sale: $160,080 +1 more

4 metrics

Proposed shares to sell 2,500 shares Exercise of stock options on <date>07/08/2026</date>

Prior 10b5-1 shares sold 10,000 shares 10b5-1 sales on <date>06/30/2026</date>

Proceeds from prior sale $160,080 Proceeds reported for 10b5-1 sale on <date>06/30/2026</date>

Form type Form 144 notice Broker‑filed resale notification

Key Terms

10b5-1, Exercise of Stock Options, Form 144

3 terms

10b5-1 regulatory

"10b5-1 Sales for CARMINE STENGONE 3565 General Atomics Court"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"Securities To Be Sold | 07/08/2026 | Exercise of Stock Options"

Form 144 regulatory

"CONTENT METADATA: "form_type": "144""

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CTNM Form 144 report mean?

It notifies the SEC of a proposed sale of securities by an affiliate. The filing shows a proposed sale of 2,500 common shares via option exercise on 07/08/2026 and records prior 10b5‑1 sales of 10,000 shares on 06/30/2026.

Who is associated with the sales reported in the CTNM filing?

The filing lists Carmine Stengone and a broker relationship. It records prior 10b5-1 sales by Carmine Stengone and shows Morgan Stanley Smith Barney LLC as the broker handling the transactions.

How many shares were sold under the 10b5‑1 plan in the past three months for CTNM?

The excerpt shows 10,000 shares sold on 06/30/2026. The reported transaction produced $160,080 in proceeds as stated in the filing for that sale.

What mechanism is being used to sell the 2,500 CTNM shares?

The proposed sale is via exercise of stock options for cash. The filing explicitly labels the method as an Exercise of Stock Options with cash treatment and a proposed sale date of 07/08/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/08/2026 - 04:39 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001861519
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Contineum Therapeutics, Inc.
SEC File Number	001-42001
Address of Issuer	3565 General Atomics Court, Suite 200 San Diego CALIFORNIA 92121
Phone	8583335280
Name of Person for Whose Account the Securities are To Be Sold	CARMINE STENGONE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2500	36400.00	32723877	07/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/08/2026	Exercise of Stock Options	Issuer			2500	07/08/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for CARMINE STENGONE 3565 General Atomics Court, Suite 200 San Diego CA 92121	Common	06/30/2026	10000	160080.00

144: Remarks and Signature

Remarks
Date of Notice	07/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Carmine Stengone
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)